Market Tracker

05/27 5:16pm ET

Mesoblast Ltd (NASDAQ:MESO)

6.91
Delayed Data
As of May 27
 +0.03 / +0.44%
Today’s Change
4.26
Today|||52-Week Range
16.25
+8.65%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close6.88
Today’s open6.84
Day’s range6.81 - 6.91
Volume5,403
Average volume (3 months)40,425
Market cap$461.5M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-33.20%
Earnings growth (this year)+20.81%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+13.25%
P/E ratio--
Price/Sales54.36
Price/Book0.98

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.26+2.54%
CFMSConforMIS Inc+0.13+1.80%
VASCVascular Solutions I...+0.20+0.52%
RTIXRTI Surgical Inc+0.02+0.52%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateAugust 23, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$17.1M
Annual profit (last year)-$99.4M
Net profit margin-582.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Executive Director &
MD
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts